Coronavirus
Covid-19 Testing: Saudi Arabia, Chinese Firm Sign US$265mn Deal

Saudi Arabia has entered into a US$265 million ((Saudi Rials 995 million) deal with a Chinese firm to ramp up coronavirus (Covid-19) testing.
The Kingdom, which eased its 24-hour curfew, excluding hotspots such as the Holy City of Mecca, said in a statement that the agreement with China’s Beijing Genome Institute (BGI) will provide for nine million COVID-19 tests, which would be conducted by “500 experts, specialists, and technicians” to be brought in from China.
As part of the agreement, six large regional laboratories will also be set up in the kingdom. This will include a “mobile laboratory with a production capacity of 10,000 tests daily”, the government statement added.
With the highest number of infections in the Arab world, Saudi Arabia is struggling to contain the virus with the deaths from Covid-19 on Sunday rising to 139 and confirmed infections to 17,522. Recoveries reported are 2,357.
Though according to the Saudi Press Agency, a nationwide curfew has been relaxed between 9 am and 5 pm, with malls and retailers allowed to reopen until May 13, Mecca and other areas still remain under complete lockdown. The highest number of infections have been recorded in Mecca despite the city being completely cordoned off.
Saudi Arabia suspended the year-round ‘umrah’ pilgrimage and is yet to announce if they will allow Haj pilgrimage to go ahead as scheduled.
Economy1 month agoNumber of Workers in GCC Countries Increase From 2021 to 2025
OER Magazines2 months agoDossier Oman: Banking, Finance & Insurance Special Edition
Magazines4 weeks agoOER Magazine April 2026 Issue
Oman1 month agoREVIEW: WHOOP and the Rise of Performance Luxury
Economy2 months agoOPINION: War, Climate, and the Costs We Choose Not to See
Lifestyle4 weeks agoAP x Swatch Royal Pop: A Rule-Breaking Collaboration That Takes the Royal Oak Off the Wrist
Economy1 month agoElectricity Tariffs Reduced for Residential Use – What It Means for You
News1 month agoANALYSIS: Oil Slips As Peace Hopes Reprice Middle East Risk, But Supply Tightness Keeps Market On Edge





































